We have located links that may give you full text access.
[Safety and efficacies of ultrasound-guided sclerotherapy of uterine fibroids with lauromacrogol].
Zhonghua Yi Xue za Zhi [Chinese medical journal] 2014 July 23
OBJECTIVE: To evaluate the safety and efficacies of ultrasound-guided sclerotherapy of uterine fibroids with lauromacrogol.
METHODS: A total of 102 consecutive premenopausal women with 113 uterine fibroids were enrolled. The treatment of lauromacrogol was performed under the guidance of ultrasound. Both conventional and color Doppler ultrasound were performed before treatment and at Month 1, 3, 6 and 12 after treatment. The changes of tumor volume reductions and vascular flow were analyzed and compared. And the alteration of symptoms was evaluated by the symptom severity score (SSS) questionnaire. And adverse events were also assessed during and after treatment.
RESULTS: At Month 1, 3, 6 and 12 after treatment, the mean volume of fibroids decreased by 40%, 47%, 58% and 70% respectively. And the differences had statistical significance before and after treatment (P < 0.05). The clinical symptoms alleviated greatly or even disappeared. And the differences in SSS before and after treatment were also statistically significant (P = 0.000). There was no onset of severe adverse events.
CONCLUSION: Both safe and efficacious, ultrasound-guided sclerotherapy of uterine fibroids with lauromacrogolis offers an alternative option for patients with fertility requirements.
METHODS: A total of 102 consecutive premenopausal women with 113 uterine fibroids were enrolled. The treatment of lauromacrogol was performed under the guidance of ultrasound. Both conventional and color Doppler ultrasound were performed before treatment and at Month 1, 3, 6 and 12 after treatment. The changes of tumor volume reductions and vascular flow were analyzed and compared. And the alteration of symptoms was evaluated by the symptom severity score (SSS) questionnaire. And adverse events were also assessed during and after treatment.
RESULTS: At Month 1, 3, 6 and 12 after treatment, the mean volume of fibroids decreased by 40%, 47%, 58% and 70% respectively. And the differences had statistical significance before and after treatment (P < 0.05). The clinical symptoms alleviated greatly or even disappeared. And the differences in SSS before and after treatment were also statistically significant (P = 0.000). There was no onset of severe adverse events.
CONCLUSION: Both safe and efficacious, ultrasound-guided sclerotherapy of uterine fibroids with lauromacrogolis offers an alternative option for patients with fertility requirements.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app